<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01895517</url>
  </required_header>
  <id_info>
    <org_study_id>TRIUC1312</org_study_id>
    <secondary_id>UMIN000010843</secondary_id>
    <nct_id>NCT01895517</nct_id>
  </id_info>
  <brief_title>CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）</brief_title>
  <official_title>Randomized Controlled Trial to Evaluate the Efficacy of Concurrent Liquid-based Cytology ( LBC) and HPV DNA Testing Versus LBC Alone for the Primary Cervical Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Keio University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jikei University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess efficacy of the screening with concurrent liquid-based
      cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 7, 2013</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of cervical intraepithelial neoplasia(CIN)3 or worse during the whole period</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of CIN3 or worse at baseline, and two years, four years, and six years post baseline</measure>
    <time_frame>2 years, 4 years, 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of CIN2 or worse at baseline, and two years, four years, and six years post baseline</measure>
    <time_frame>2 years, 4 years, 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of CIN1 or worse at baseline, and two years, four years, and six years post baseline</measure>
    <time_frame>2 years, 4 years, 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of invasive cancer at baseline, and two years, four years, and six years post baseline</measure>
    <time_frame>2 years, 4 years, 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of cervical cytology performance</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of colposcopy and biopsy performance</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18471</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>LBC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical cancer screening by using liquid based cytology as a standard screening modality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LBC plus HPV DNA testing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LBC</intervention_name>
    <description>Cervical cancer screening by using liquid based cytology as a standard screening modality</description>
    <arm_group_label>LBC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LBC plus HPV DNA testing</intervention_name>
    <description>Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality</description>
    <arm_group_label>LBC plus HPV DNA testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women aged 30-64 years old

          2. Participants provided written informed consent

        Exclusion Criteria:

        Women who

          1. will receive planed HPV DNA testing by local governmental cervical cancer program next
             six years

          2. have had cervical invasive cancer before

          3. have undergone cervical conization

          4. have undergone hysterectomy

          5. have had or have the cytological abnormalities and are under follow-up

          6. are pregnant

          7. are judged ineligible for this trial by physician
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>School of Medicine, Keio University</name>
      <address>
        <city>Shinjuku</city>
        <state>Tokyo</state>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2013</study_first_submitted>
  <study_first_submitted_qc>July 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

